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Although transintestinal cholesterol efflux has been
identified as an important means of clearing excess
sterols, the mechanisms that underlie this process
remain poorly understood. Here, we show that
magro, a direct target of the Drosophila DHR96
nuclear receptor, is required in the intestine to main-
tain cholesterol homeostasis.magro encodes a LipA
homolog that is secreted from the anterior gut into
the intestinal lumen to digest dietary triacylglycerol.
Expression of magro in intestinal cells is required to
hydrolyze cholesterol esters and promote choles-
terol clearance. Restoring magro expression in the
intestine of DHR96 mutants rescues their defects in
triacylglycerol and cholesterol metabolism. These
studies show that the central role of the intestine in
cholesterol efflux has been conserved through evolu-
tion, that the ancestral function of LipA is to coordi-
nate triacylglycerol and cholesterol metabolism,
and that the region-specific activities ofmagro corre-
spond to the metabolic functions of its upstream
regulator, DHR96.
INTRODUCTION
Coordinate regulation of lipid metabolism is central to human
health, and disruption of this process leads to a range of meta-
bolic disorders, including obesity and cardiovascular disease.
Normal lipid homeostasis ismaintained by balancing dietary lipid
uptake and synthesis with lipid catabolism and excretion. Under
normal feeding conditions, dietary lipids, such as triacylglycerol
(TAG) and cholesterol esters, are broken down into free fatty
acids, monoacylglycerols, and free sterols in the lumen of the
intestine. These digested lipids can then be absorbed by the
intestinal cells, where TAG is resynthesized and packaged
together with cholesterol, cholesterol esters, and carrier proteins
to form lipoprotein particles that are trafficked throughout the
body. These lipids can be either utilized by cells or deposited
in storage tissues, such as the adipose and liver. Under condi-
tions of excess lipids, TAG and cholesterol esters are broken
down and free fatty acids can be utilized for energy, whereas122 Cell Metabolism 15, 122–127, January 4, 2012 ª2012 Elsevier Inexcess cholesterol is excreted from the body (Lusis and Paju-
kanta, 2008; van der Velde et al., 2010).
Nuclear receptors (NRs) are ligand-regulated transcription
factors that play essential roles in multiple aspects of lipid
homeostasis. Many NRs bind small lipophilic compounds,
such as fatty acids, sterols, and other metabolic intermediates,
and coordinate multiple aspects of metabolism by directing
specific changes in gene expression. One example of this is
LXRa (NR1H3), which binds oxysterols and promotes the modi-
fication and clearance of excess sterols (Kalaany and Mangels-
dorf, 2006). In addition, LXRa is required to maintain proper
TAG levels, at least in part through the regulation of SREBP-
mediated fat synthesis (Schultz et al., 2000). Thus, LXRa
activity is central to both TAG and cholesterol homeostasis,
although much remains to be learned about the roles of spe-
cific LXR target genes in mediating these key metabolic
functions.
We have been studying aDrosophila homolog of LXR, DHR96,
as a simple system to understand the physiological and molec-
ular roles for this family of NRs and their target genes. Bio-
chemical and genetic studies of DHR96 have shown that it
shares the central metabolic functions of itsmammalian counter-
part. DHR96 binds cholesterol and is required for normal choles-
terol homeostasis, withDHR96 null mutants exhibiting an 20%
increase inwhole animal cholesterol levels due, at least in part, to
increased npc1b expression (Horner et al., 2009; Bujold et al.,
2010). In addition, DHR96 mutants display an  50% decrease
in whole animal TAG levels that can be attributed to an inability
to break down dietary TAG due to reduced expression of the
intestinal lipase Magro (CG5932) (Sieber and Thummel, 2009).
Interestingly, magro transcription responds to dietary choles-
terol levels and this regulation is dependent on DHR96 function,
providing a potential link between cholesterol levels, DHR96,
and TAG homeostasis (Horner et al., 2009; Bujold et al., 2010).
Moreover, although Magro protein is most similar to mammalian
gastric lipase (38% identity, 56% similarity), the second most
similar protein is LipA (32% identity, 50% similarity), which has
both TAG lipase and cholesterol esterase activities (Ameis
et al., 1994). Genetic studies have demonstrated a central role
for LipA in maintaining proper cholesterol levels in mice (Du
et al., 2001). Similar phenotypes are seen in human LipAmutants
suffering from cholesterol ester storage disease (CESD) and
Wolman’s disease (Burke and Schubert, 1972). These observa-
tions raise the possibility that magro, in addition to controlling
TAG homeostasis, may regulate cholesterol homeostasis andc.
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Figure 1. magro Maintains Proper Cholesterol
Levels and Has Cholesterol Esterase Activity
(A) RNAi for magro results in elevated cholesterol levels
similar to those seen in DHR96 mutants. Wild-type (WT),
Act-GAL4/+, and UAS-magro-RNAi/+ control flies, along
with DHR961 mutants and Act-GAL4/UAS-magro-RNAi
animals (Act>mag-RNAi), were assayed for total choles-
terol levels. The data were normalized to protein levels and
are presented relative to a wild-type level of 100%.
(B) RNAi for magro results in reduced cholesteryl ester
hydrolase activity (CE) in intestines. Intestines dissected
from both Act-Gal4/+ control and Act-GAL4/UAS-magro-
RNAi (magro RNAi) animals were homogenized and
increasing amounts of lysate were tested for cholesteryl
ester hydrolase activity by assaying for the release of free
cholesterol from a cholesterol acetate substrate. The
y-axis shows mg/ml of free glycerol released.
(C) Purified GST-Magro protein has CE activity. Recom-
binant GST and GST-Magro were purified as described
(Sieber and Thummel, 2009) and increasing amounts of
protein were assayed for CE activity. The y-axis shows mg/
ml of free glycerol released.
(D) Intestine-specific RNAi for magro results in elevated
levels of esterified cholesterol. Free, esterified, and total
cholesterol levels were measured from Mex-GAL4/+
control and Mex-GAL4/UAS-magro-RNAi (magro RNAi)
animals. Error bars represent ± SEM (*p < 0.05,
**p < 0.0001).
Cell Metabolism
Regulation of Lipid HomeostasisDHR96may function throughmagro to help coordinate TAG and
cholesterol metabolism.
In this study we show that loss of magro function leads to an
increase in cholesterol levels similar to that seen in DHR96
mutants. We show that Magro, like LipA, has cholesterol
esterase activity, and this enzyme is required in intestinal cells
to maintain cholesterol homeostasis. In contrast, the TAG lipase
activity of Magro arises from the anterior end of the gut and acts
in the intestinal lumen to facilitate dietary fat uptake. Restoring
magro expression in the intestine of the DHR96 mutant is suffi-
cient to rescue their lean phenotype and elevated levels of
cholesterol. Our data support the model that DHR96 functions
through magro in the intestine to coordinate both dietary TAG
breakdown and the clearance of excess sterols.
RESULTS
magro Is Required for Normal Cholesterol Homeostasis
The regulation of magro transcription by dietary cholesterol
combined with its significant homology to LipA prompted us to
test whether magro function is required for cholesterol homeo-
stasis. DHR961 null mutants grown on a normal diet display
elevated levels of cholesterol compared to genetically matched
wild-type controls (Figure 1A), similar to the results seen when
DHR96 mutant larvae are subjected to a high cholesterol diet
(Horner et al., 2009). Interestingly, ubiquitous RNA interference
(RNAi)-mediated silencing of magro expression using Act-
GAL4, as done previously (Sieber and Thummel, 2009), leads
to a similar phenotype (Figure 1A). Taken together with our earlier
work, which showed that both DHR96mutants andmagro RNAi
animals have significantly lower levels of TAG, these data
suggest that DHR96 functions through transcriptional regulation
of magro to coordinate TAG and cholesterol homeostasis in
Drosophila.Cellmagro Regulates Cholesterol Homeostasis by Breaking
Down Stored Cholesterol Esters
In order to determine whether Magro can act like LipA by
cleaving cholesterol esters in addition to its TAG lipase activity,
we assayed for cholesterol esterase activity in control andmagro
RNAi animals (Ameis et al., 1994). Although control intestinal
lysates exhibit a high level of cholesterol esterase activity in
a dose-dependent manner, the lysates frommagroRNAi animals
display an  50% decrease in enzymatic function (Figure 1B).
Moreover, purified recombinant GST-Magro efficiently cleaves
a cholesterol ester substrate in vitro, demonstrating that these
effects are a direct result of Magro enzymatic activity (Figure 1C).
Taken together with our earlier biochemical studies, this result
shows that Magro is a bifunctional enzyme that can act as both
a TAG lipase and a cholesterol esterase (Sieber and Thummel,
2009).
If decreased intestinal cholesterol esterase activity causes the
elevated cholesterol levels seen in themagro RNAi animals, then
we should see an increase in stored cholesterol esters when
magro expression is specifically silenced in the intestine. Consis-
tent with this proposal, we see a significant increase in the levels
of both total cholesterol and cholesterol esters in Mex>magro
RNAi animals, whereas free cholesterol levels remain unchanged
(Figure 1D). Elevated cholesterol levels can also be detected
clearly in isolated intestines, supporting a role formagro in main-
taining cholesterol levels in this tissue (Figure S1). These data
support the model that Magro maintains cholesterol homeo-
stasis through its ability to directly break down stored cholesterol
esters in the intestine.
magro Is Expressed throughout the Digestive Tract
The similarity between lipase sequences complicates our ability
to raise specific antibodies against Magro. Accordingly, we
determined the pattern of Magro expression using a genomicMetabolism 15, 122–127, January 4, 2012 ª2012 Elsevier Inc. 123
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Figure 2. Magro Is Expressed in the Proventriculus and Midgut
(A) Magro-EGFP (green) expression inmid-third instar larvae is restricted to the
intestine and accumulates to high levels in the anterior region of the proven-
triculus (Prov) (A, arrow in C). Antibody staining for EGFP also revealed lower
levels of punctate expression in the cytoplasm of enterocytes.
(B) Higher resolution images of the proventriculus revealed Magro-EGFP in
large vesicles that extend from the abundant expression at the anterior end of
the proventriculus toward the junction with the midgut lumen (yellow boxes
in C, D, and E, shown in panels F, G, and H). Lysotracker Red stains the large
acidic vesicles that contain Magro-EGFP protein (D, E, G, and H).
Cell Metabolism
Regulation of Lipid Homeostasismagro-EGFP transgenic line. This construct contains 7 kb of
genomic DNA spanning the magro locus with 5 kb of upstream
promoter sequences and the EGFP gene fused in-frame to the
30-end of the magro protein coding region. Magro-EGFP is ex-
pressed specifically in the intestine with the highest levels of
protein accumulation in the anterior region of the proventriculus
(Figure 2A). The proventriculus is a bulb shaped structure at the
anterior end of the gut that consists of three distinct cell layers
(Figure S2). Magro-EGFP is expressed in the anterior half of
the outermost layer of cells in the proventriculus (Figures 2C,
arrow; and S2). In addition, protein is clearly visible in large vesi-
cles that lie posterior to this region of expression (Figures 2C–2E,
yellow boxes). These are acidic vesicles that stain positive for
Lysotracker Red (Figures 2F–2H), consistent with the acid
lipase activity of Magro and LipA. Interestingly, visualization of
vesicles using CD8-EGFP in this region reveals that they move
in a posterior direction toward the intestine, providing a potential
mechanism to deliver digestive enzymes, such as Magro, into124 Cell Metabolism 15, 122–127, January 4, 2012 ª2012 Elsevier Inthe intestinal lumen (Figure S3). Lower levels of Magro-EGFP
protein can also be seen in the major cell type of the intestine,
the enterocytes, in a punctate cytoplasmic pattern (Figure 2B).
Interestingly, we do not observe Magro-EGFP in large Lyso-
tracker-positive vesicles in these cells. Taken together, these
observations suggest that Magro is trafficked differently in
different cell types of the digestive tract, raising the possibility
that the cholesterol esterase and TAG lipase activities of this
enzyme are regionally specified.
magro Acts within the Intestinal Lumen to Maintain
Triacylglycerol Homeostasis
As a first step toward determining whether the enzymatic activ-
ities of Magro localize regionally within the intestine, we raised
DHR96mutant andmagro RNAi animals on a diet supplemented
with pancreatin. This enzymatic mixture of pancreatic enzymes,
including TAG lipase and cholesterol esterase, should specifi-
cally restore TAG lipase and cholesterol esterase activity in the
lumen of the gut. Although pancreatin supplementation had no
effect on TAG levels in control animals, this diet restored wild-
type levels of TAG in both DHR96 and magro RNAi animals
(Figures 3A and 3B). Conversely, pancreatin supplementation
had no impact on the elevated cholesterol levels in these animals
(Figure 3C and 3D). These results are consistent with those seen
when wild-type flies are treated with Orlistat (tetrahydrolipstatin),
which acts as a competitive inhibitor of secreted lipases and cho-
lesterol esterases inside the lumen of the intestine (Borgstro¨m,
1988). Although Orlistat treatment is sufficient to decrease whole
animal TAG levels, as seen previously (Sieber and Thummel,
2009), it has no significant effect on total cholesterol levels (Fig-
ure S4). These data confirm our earlier studies indicating that
Magro functions in the intestinal lumen to maintain appropriate
levels of TAG, and demonstrate that its effects on cholesterol
homeostasis are conferred within the cells of the intestinal tract.
magro Functions in the Proventriculus to Promote
the Breakdown of Dietary Triacylglycerol
The apparent vesicular trafficking of Magro protein from the
proventriculus toward the body of the midgut provides a mecha-
nism to explain its delivery into the lumen of the intestine. If this
model is correct, then disrupting magro function specifically in
the proventriculus should have an effect on TAG levels but little
or no effect on cholesterol homeostasis. To test this hypothesis,
we used the bab1-GAL4 driver, which is expressed highly in the
proventriculus and weakly near themidgut-hindgut junction (Fig-
ure 4A) (Cabrera et al., 2002). Using this construct to direct
magro RNAi resulted in a significant decrease in whole animal
TAG levels (Figure 4B), similar to that seen with the panintestinal
Mex-GAL4 driver (Sieber and Thummel, 2009). In contrast,
proventriculus-specific magro RNAi has no effect on total
cholesterol levels (Figure 4C). We conclude that the TAG meta-
bolic functions of Magro are restricted to the proventriculus,
whereas its cholesterol regulatory function resides outside the
proventriculus in the intestine.
DHR96 Regulates Major Aspects of Lipid Metabolism
through Its Target Gene magro
If decreased magro expression is physiologically relevant to the
cholesterol accumulation phenotype seen in DHR96 mutants,c.
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Figure 3. Magro Enzymatic Activity Is Not Required in the
Intestinal Lumen to Maintain Cholesterol Homeostasis
Wild-type (WT) and Act-GAL4/+ controls, along with DHR961mutants
and Act-GAL4/UAS-magro-RNAi (Act>mag-RNAi) animals, were
raised on medium supplemented with 2 mg/mls pancreatin, an en-
zymatic mixture of pancreatic TAG lipase and cholesterol esterase.
(A–D)Mature adults were collected and assayed for TAG (A and B) and
cholesterol (C and D) levels. The data were normalized to protein
levels and are presented relative to a wild-type level of 100%. Error
bars represent ± SEM (**p < 0.0001).
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Regulation of Lipid Homeostasisthen restoring magro function in these animals should rescue
their defect in cholesterol homeostasis. Consistent with this
hypothesis, expressing wild-typemagro specifically in the intes-
tine of the DHR96 mutant is sufficient to reduce the cholesterol
levels in these animals (Figure 4D). This rescue, however, is not
complete, which is consistent with the multiple levels of choles-
terol metabolism that are regulated by DHR96 (Horner et al.,
2009; Bujold et al., 2010). Moreover, specific expression of
magro in the proventriculus of DHR96 mutants effectively
rescues their lean phenotype (Figure 4E) but has no significant
effect on their elevated cholesterol levels (Figure 4F). Taken
together with our other data, these results indicate that the
region-specific enzymatic activities of Magro correspond to the
major lipid metabolic functions of DHR96. DHR96 regulation of
magro expression in the proventriculus maintains an appropriate
level of TAG lipase activity in the intestinal lumen to facilitate the
breakdown of dietary lipid whereas DHR96 regulation of magro
in the body of the intestine promotes the clearance of excess
sterols.
DISCUSSION
Magro and LipA Share Conserved Functions
in Maintaining Lipid Homeostasis
Relatively little is known about the mechanisms that regulate
cholesterol metabolism in Drosophila. Most studies have
focused on DHR96 and the Niemann-Pick (NPC) disease gene
homologs, which play important roles in dietary cholesterol
absorption and intracellular cholesterol trafficking (Niwa and
Niwa, 2011). In this paper, we identify the intestine as a key tissue
for maintaining cholesterol homeostasis, and we define a central
role for the LipA homolog, Magro, in mediating this function. Like
LipA, Magro has dual enzymatic activities, cleaving both TAG
and cholesterol esters, consistent with their common fatty acid
ester bonds (Ameis et al., 1994). Mouse LipA mutants display
a lack of stored fat in the form of white adipose tissue along
with excess cholesterol esters (Du et al., 2001), reflecting the
major defects in magro RNAi animals. Similar phenotypes are
seen in human LipAmutants suffering fromCESD andWolman’sCell Metabodisease (Burke and Schubert, 1972). Patients with Wol-
man’s disease also have digestive dysfunction, which
may be related to the defects in lipid uptake that we
observe in magro RNAi animals. In addition to these
shared phenotypes, however, mammalian LipA mutants
display massive accumulations of lipid in the liver, spleen,
and intestine—defects that are not apparent in magro
RNAi animals (Du et al., 2001). Nonetheless, the parallelsbetween Magro and LipA function in flies and humans establish
Drosophila as a system to further our understanding of CESD
and Wolman’s disease and define the ancestral function for
this class of acid lipases, demonstrating their central role in the
intestine to coordinate TAG and cholesterol homeostasis.
Interestingly, the dual enzymatic functions of Magro appear to
arise from distinct regions of the intestine. Disruption of magro
function specifically in the proventriculus blocks its TAG lipolytic
activity but does not affect cholesterol levels in these animals
(Figures 4B and 4C). In contrast, magro RNAi throughout the
intestine affects both TAG and cholesterol homeostasis (Fig-
ure 1D). These region-specific activities are consistent with our
dietary supplementation studies with pancreatin and Orlistat
(Figures 3 and S4). They are also consistent with the expression
pattern of Magro-EGFP protein, providing insights into how the
dual functions of this enzyme are manifested. Magro-EGFP is
expressed abundantly in the large outer columnar cells in the
anterior half of the proventriculus (Figures 2A and S2). We also
see a stream of large acidic vesicles that originate from this
region and move in a posterior direction toward the lumen of
the intestine (Figures 2F–2H and S3). This apparent vesicular
trafficking of Magro is consistent with the cells at the anterior
end of the proventriculus having secretory functions, depositing
peritrophic matrix components into the lumen that lies between
the outer and inner cell layers of the proventriculus (King, 1988)
(Figure S2). The peritrophic matrix is a meshwork of chitin and
glycoproteins that provides a protective lining within the gut,
much like the mucosal layer of the mammalian intestine (Hege-
dus et al., 2009). The observation that the Magro-EGFP vesicles
reside in the same region of the proventriculus as the developing
peritrophic matrix suggests that they are synthesized and ex-
ported into the lumen of the gut in a similar manner. This also rai-
ses the possibility that the digestive enzymes that are embedded
in the peritrophic matrix may originate from vesicular trafficking
in the proventriculus. Like magro, many genes with predicted
digestive functions, including glucosidases, mannosidases, and
endopeptidases, are regulated by DHR96 and expressed in the
intestine (Sieber and Thummel, 2009). Several genes that con-
tribute to the peritrophic matrix are also regulated by DHR96.lism 15, 122–127, January 4, 2012 ª2012 Elsevier Inc. 125
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Figure 4. DHR96 Regulation of magro in Distinct Regions of the
Intestine Coordinates TAG and Cholesterol Homeostasis
(A) bab1-GAL4 drives high levels of UAS-NLS-DsRed expression in the
proventriculus (red arrow) with no detectable expression in the body of the
midgut (black arrow) and low levels near the midgut-hindgut junction (white
arrow).
(B and C) Proventriculus-specific RNAi for magro results in reduced levels of
TAG but does not affect cholesterol. bab1-GAL4/+ and UAS-magro-RNAi/+
control flies, along with bab1-GAL4/UAS-magro-RNAi (bab1>mag-RNAi)
animals were assayed for TAG (B) and cholesterol (C). The data were nor-
malized to protein levels and are presented relative to a wild-type level
of 100%.
(D) Midgut-specific expression of magro is sufficient to partially rescue the
elevated cholesterol levels in DHR96 mutants. Wild-type (WT) and DHR96
mutants carrying theMex-GAL4 driver alone, UAS-magro transgene alone, or
both Mex-GAL4 and UAS-magro (Mex>mag) to express magro in the midgut
were assayed for total cholesterol levels. The data were normalized to protein
levels and are presented relative to a wild-type level of 100%.
(E and F) Proventriculus-specific expression of magro is sufficient to rescue
the lean phenotype of DHR96 mutants, but has no effect on its elevated
cholesterol levels. Wild-type (WT) and DHR96 mutants carrying the bab1-
GAL4 driver alone, UAS-magro transgene alone, or both bab1-GAL4 and
UAS-magro (bab1>mag) to expressmagro in the proventriculus were assayed
for TAG (E) and cholesterol (F). The data were normalized to protein levels and
are presented relative to a wild-type level of 100%. Error bars represent ± SEM
(*p < 0.01 **p < 0.0001).
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126 Cell Metabolism 15, 122–127, January 4, 2012 ª2012 Elsevier InIt would be interesting to determine whether the proventriculus
synthesizes and secretes these proteins in a coordinated
manner.
In addition to its abundant expression in the proventriculus,
Magro-EGFP is also present at lower levels throughout the intes-
tine, visible as punctate cytoplasmic staining in the entero-
cytes (Figure 2B). This expression pattern provides a possible
mechanism to explain the role of Magro in maintaining choles-
terol homeostasis. We propose that Magro acts as a cholesterol
esterase in the enterocytes, breaking down stored cholesterol to
facilitate its elimination from the intestine. This model is consis-
tent with the neutral lipid stores that are known to reside in the
Drosophila intestine, second only to the fat body. It is also
consistent with recent evidence that LipA acts as cholesterol
esterase in macrophage foam cells to promote ABCA1-medi-
ated cholesterol efflux (Ouimet et al., 2011). These data suggest
that LipA and Magro may break down stored cholesterol esters
upstream of reverse cholesterol transport and transintestinal
cholesterol efflux to promote the clearance of excess sterols.
Tissue-specific studies of LipA function in the pancreas and
intestine may provide a clearer understanding of its relationship
to the apparent exocrine role of Magro in the proventriculus and
its ability to promote cholesterol clearance in the intestine.
Finally, our data provide new directions in understanding the
roles of LXR family members in lipid metabolism. Both DHR96
mutants and magro RNAi animals display reduced levels of
TAG and elevated levels of cholesterol, and restoring magro
expression in the intestines of DHR96 mutant animals largely
rescues these defects, establishing magro as a key target for
DHR96 regulation (Figures 1 and 4C) (Sieber and Thummel,
2009). These functions for DHR96 parallel those of its mam-
malian homolog, LXR. LXR activation, specifically in the intes-
tine, results in a dramatic increase in fecal sterol excretion that
correlates with increased expression of the ABCG5/ABCG8
sterol transporter (van der Veen et al., 2009; Lo Sasso et al.,
2010). This observation suggests that LXR promotes reverse
cholesterol transport in this tissue, which represents the best
characterized mechanism for eliminating excess cholesterol
from the body. Reverse cholesterol transport involves HDL-
mediated transport of cholesterol from peripheral tissues to the
hepatobiliary tract, leading to the removal of excess sterol by
biliary excretion from the body. However, genetic studies of
key components in biliary cholesterol excretion, such as abcb4
mutants and abcg5/abcg8 double mutants, have challenged
the importance of reverse cholesterol transport for cholesterol
excretion and have led to the proposal that the intestine plays
a more direct role in this process (van der Velde et al., 2010).
These studies shift the focus of cholesterol efflux toward the
intestine and implicate a central role for LXR in regulating intes-
tinal cholesterol clearance, not only through regulation of reverse
cholesterol transport but also through novel targets involved in
transintestinal cholesterol efflux (Kruit et al., 2005). In addition,
our evidence that intestinal cholesterol esterase activity is critical
for clearing excess sterol from the body suggests that acid
lipases such as LipA may function downstream from LXR to
maintain cholesterol homeostasis. Although there is no direct
evidence that LXR regulates LipA expression, a recent study
showed that elevated levels of oxidized LDL can repress LipA
expression in endothelial cells, an effect that can be reversedc.
Cell Metabolism
Regulation of Lipid Homeostasisby treatment with LXR agonists (Heltianu et al., 2011). Further
studies are required to determine whether the regulatory links
between LXR, LipA, and cholesterol homeostasis have been
conserved through evolution and whether Drosophila can be
used as a simple model system to better define the mechanisms
of transintestinal cholesterol efflux.
EXPERIMENTAL PROCEDURES
Fly Stocks
The following stocks were used in this study: Canton S, DHR961 (King-Jones
et al., 2006),Mex-Gal4 (Phillips and Thomas, 2006), Act-Gal4/CyO (Blooming-
ton # 25374), UAS-magro (Sieber and Thummel, 2009), UAS-DHR96 (Horner
et al., 2009), and bab1-GAL4/TM3 (Cabrera et al., 2002). Flies weremaintained
on standard Bloomington Stock Center medium with malt at 25C.
Metabolite Assays
Newly eclosed adult male flies were aged 5–7 days prior to use for all experi-
ments. TAG and cholesterol assays were conducted as described (Horner
et al., 2009; Sieber and Thummel, 2009) All results shown are derived from
12 samples of 5 animals collected from each genotype under each condition,
and repeated at least 3 times. A representative experiment is shown in each
figure.
Statistical Analyses
Statistical analysis was done for each experiment using an unpaired two-tailed
Student’s t-test with unequal variance. All quantitative data are reported as the
mean ± SEM. The n and SEM for each data point is derived from the 12
samples of 5 animals collected from each genotype under each condition.
SUPPLEMENTAL INFORMATION
Supplemental Information include Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.cmet.2011.11.011.
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